References
- Chang, S. Y., Park, S. G., Kim, S., and Kang, C. Y. (2002) Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation. J. Biol. Chem. 277, 8388–8394 https://doi.org/10.1074/jbc.M108792200
- Folkman, J. (2002) Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29 (6 Suppl. 16), 15-18 https://doi.org/10.1053/sonc.2002.37263
- Folkman, J. (2003) Fundamental concepts of the angiogenic process. Curr. Mol. Med. 3, 643-651 https://doi.org/10.2174/1566524033479465
- Gervaz, P. and Fontolliet, C. (1998) Therapeutic potential of the anti-angiogenesis drug TNP-470. Int. J. Exp. Pathol. 79, 359-362 https://doi.org/10.1046/j.1365-2613.1998.00087.x
- Hayes, A. J., Li, L. Y., and Lippman, M. E. (1999) Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment. BMJ 318, 853-856 https://doi.org/10.1136/bmj.318.7187.853
- Inoue, K., Slaton, J. W., Davis, D. W., Hicklin, D. J., McConkey, D. J., et al. (2000) Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel. Clin. Cancer Res. 6, 2635-2643
- Kao, J., Houck, K., Fan, Y., Haehnel, I., Libutti, S. K., et al. (1994) Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J. Biol. Chem. 269, 25106-25119
- Kato, T., Sato, K., Kakinuma, H., and Matsuda, Y. (1994) Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res. 54, 5143-5147
- Ko, Y. G., Park, H., Kim, T., Lee, J. W., Park, S. G., et al. (2001) A cofactor of tRNA synthetase, p43, is secreted to upregulate proinflammatory genes. J. Biol. Chem. 276, 23028-23033 https://doi.org/10.1074/jbc.M101544200
- Moser, T. L., Stack, M. S., Asplin, I., Enghild, J. J., Hojrup, P., et al. (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. USA 96, 2811–2816
- Moser, T. L., Kenan, D. J., Ashley, T. A., Roy, J. A., Goodman, M. D., et al. (2001) Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc. Natl. Acad. Sci. USA 98, 6656-6661
- O'Reilly, M. S. (2002) The combination of antiangiogenic therapy with other modalities. Cancer J. 8 (Suppl. 1), S89-99
- Park, S. G., Kang, Y. S., Ahn, Y. H., Lee, S. H., Kim, K. R., et al. (2002) Dose-dependent biphasic activity of tRNA synthetaseassociating factor, p43, in angiogenesis. J. Biol. Chem. 277, 45243-45248 https://doi.org/10.1074/jbc.M207934200
- Park, S. G., Shin, H., Shin, Y. K., Lee, Y., Choi, E. C., et al. (2005) The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am. J. Pathol. 166, 387-398 https://doi.org/10.1016/S0002-9440(10)62262-6
- Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., et al. (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin. Cancer Res. 5, 257–265
- Quevillon, S., Agou, F., Robinson, J. C., and Mirande M. (1997) The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J. Biol. Chem. 272, 32573–32579 https://doi.org/10.1074/jbc.272.51.32573
- Schwarz, M. A., Kandel, J., Brett, J., Li, J., Hayward, J., et al. (1999) Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J. Exp. Med. 190, 341-354 https://doi.org/10.1084/jem.190.3.341
- Slaton, J. W., Perrotte, P., Inoue, K., Dinney, C. P., and Fidler, I. J. (1999) Interferon-a-mediated down-regulation of angiogenesis- related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule. Clin. Cancer Res. 5, 2726–2734
- Ye, D., Mendelsohn, J., and Fan, Z. (1999) Augmentation of a humanized anti-HER2 Mab 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor Mab C225. Oncogene 18, 731-738 https://doi.org/10.1038/sj.onc.1202319